TNF Receptors - How They Function and Interact

Archivum Immunologiae et Therapiae Experimentalis

Volumn 45, Issue 4, 1997, Pages 263-270

  Bigda, Jacek ^a   Holtmann, Helmut ^b  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Cytokines; Inflammation; Signal transduction; TNF receptors; Tumor necrosis factor (TNF)

Indexed keywords

TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL; HUMAN; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION;

EID: 0031308291     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (78)

1. ABE Y., GATANAGA M., OSUKA Y., KIMURA S., BURGER R. A., GRANGER G. A. and GATANAGA T. (1993): Role of 55- and 75-kDa tumor necrosis factor membrane receptors in the regulation of intercellular adhesion molecules-1 expression by HL-60 human promyelöcytic leukemia cells in vitro. J. Immunol., 150, 5070 - 5079.
2. ADERKA D., ENGELMANN H., HORNIK V., SKORNICK Y., LEVO Y., WALLACH D. and KUSHTAI G. (1991): Increased levels of soluble receptors for tumor necrosis factor in cancer patients. Cancer Res., 51, 5602 - 5607.
3. AGGARWAL B. B., GRAFF K., SAMAL B., HIGUCHI M. and LIAO W. S. L. (1993): Regulation of two forms of the TNF receptors by phorbol ester and dibutyryl cyclic adenosine 3′,5′-monophosphate in human histiocytic lymphoma cell line U-937. Lymphokine Cytokine Res., 12, 149 - 158.
4. AGGARWAL B. B. and NATARAJAN K. (1996): Tumor necrosis factors. Development during the last decade. Eur. Cytokine Netw., 7, 93 - 124.
5. BANNER D. W., D'ARCY A., JANES W., GENTZ R., SCHOENFELD H.-J., BROGER C., LOETSCHER H. and LESSLAUER W. (1993): Crystal structure of the soluble human 55 kd TNF receptor-human TNFβ complex: implications for TNF receptor activation. Cell, 73, 431 - 445.
6. BARGETZI M. J., LANTZ M., SMITH C. G., TORTI F. M., OLSSON I., EISENBERG S. P. and STARNES H. F. JR. (1993): Interleukin-1 - induces interleukin-1 receptor antagonist and tumor necrosis factor binding protein in humans. Cancer Res., 53, 4010 - 4013.
7. BEBO B. F. JR. and LINTHICUM D. S. (1995): Expression of mRNA for 55-kDa and 75-kDa tumor necrosis factor (TNF) receptors in mouse cerebrovascular endothelium: effects of interleukin-1, interferon-γ and TNF-α on cultured cells. J. Neuroimmunol., 62, 161 - 167.
8. BEMELMANS M. H. A., GOUMA D. J. and BUURMAN W. A. (1993): LPS-induced sTNF-receptor release in vivo in a murine model. J. Immunol., 151, 5554 - 5562.
9. BIGDA J., BELETSKY I., BRAKEBUSCH C., VARFOLOMEEV Y., ENGELMANN H., BIGDA J., HOLTMANN H. and WALLACH D. (1994): Dual role of the p75 tumor necrosis factor (TNF) receptor in TNF cytotoxicity. J. Exp. Med., 180, 445 - 460.
10. BOLDIN M. P., GONCHAROV T. M., GOLTSEV Y. U. and WALLACH D. (1996): Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1 and TNF receptor-induced cell death. Cell, 85, 803 - 815.
11. BOLDIN M. P., VARFOLOMEEV E. E., PANCER Z., METT I. L., CAMONIS J. H. and WALLACH D. (1995): A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J. Biol. Chem., 279, 7795 - 7798.
12. BRAKEBUSCH C., NOPHAR Y., KEMPER O., ENGELMANN H. and WALLACH D. (1992): Cytoplasmic truncation of the p55 tumour necrosis factor (TNF) receptor abolishes signalling, but not induced shedding of the receptor. EMBO J., 11, 943 - 950.
13. BROCKHAUS M., SCHONEFELD H.-J., SCHLAEGER E.-J., HUNZIKER W., LESSLAUER W. and LOETSCHER H. (1990): Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc. Natl. Acad. Sci. USA, 87, 3127 - 3131.
14. CHINNAIYAN A. M., O'ROURKE K., TEWARI M. and DIXIT V. M. (1995): FADD, a novel death domain-containing protein interacts with the death domain of Fas and initiates apoptosis. Cell, 81, 505 - 512.
15. COLOTTA F., RE F., MUZIO M., BERTINI R., POLENTARUTTI N., SIRONI M., GIRI J. G., DOWER S. K., SIMS J. E. and MANTOVANI A. (1993): Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science, 261, 472 - 475.
16. COPE A. P., ADERKA D., DOHERTY M., ENGELMANN H., GIBBONS D., JONES A. C., BRENNAN F. M., MAINI R. N., WALLACH D. and FELDMANN M. (1992): Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluids of patients with rheumatic diseases. Arthritis Rheum., 35, 1160 - 1169.
17. ECK M. J. and SPRANG S. R. (1989): The structure of tumor necrosis factor-α at 2.6 A resolution: implications for receptor binding. J. Biol. Chem., 264, 17595 - 17605.
18. ENGELMANN H., HOLTMANN H., BRAKEBUSCH C., SHEMER AVNI Y., SAROV I., NOPHAR Y., LEITNER O. and WALLACH D. (1990): Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity. J. Biol. Chem., 265, 14497 - 14504.
19. ENGELMANN H., NOVICK D. and WALLACH D. (1990): Two tumor necrosis factor-binding proteins purified from human urine. Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors. J. Biol. Chem., 265, 1531 - 1536.
20. ESPEVIK T., BROCKHAUS M., LOETSCHER H., NONSTAD U. and SHALABY R. (1990): Characterization of binding and biological effects of monoclonal antibodies against a human tumor necrosis factor receptor. J. Exp. Med., 171, 415 - 426.
21. FISCHER C. J., AGOSTI J. M., OPAL S. M., LOWRY S. F., BALK R. A., SADOFF J. C., ABRAHAM E., SCHEIN R. M. H. and BENJAMIN E. (1996): Treatment of septic shock with the tumor necrosis factor receptor: Fc fusion protein. N. Engl. J. Med., 334, 1697 - 1702.
22. GEHR G., GENTZ R., BROCKHAUS M., LOETSCHER H. and LESSLAUER W. (1992): Both tumor necrosis factor receptor types mediate proliferative signals in human mononuclear cell activation. J. Immunol., 149, 911 - 917.
23. GRELL M., DOUNI E., WAJANT H., LOHDEN M., CLAUSS M., MAXEINER B., GEORGOPOULOS S., LESSLAUER W., KOLLIAS G., PFIZENMAIER K. and SCHEURICH P. (1995): The transmembrane form of tumor necrosis factor (TNF) is the prime activating ligand of the 80 kDa TNF receptor. Cell, 83, 793 - 802.
24. GRELL M., SCHEURICH P., MEAGER A. and PFIZENMAIER K. (1993): TR60 and TR80 tumor necrosis factor (TNF)-receptors can independently mediate cytolysis. Lymphokine Cytokine Res., 12, 143 - 148.
25. GRELL M., ZIMMERMANN G., HUELSER D., PFIZENMAIER K. and SCHEURICH P. (1994): TNF receptors TR60 and TR80 can mediate apoptosis via induction of distinct signal pathways. J. Immunol., 153, 1963 - 1972.
26. HELLER R. A., SONG K., FAN N. and CHANG D. J. (1992): The p70 tumor necrosis factor receptor mediates cytotoxicity. Cell, 70, 47 - 56.
27. HIGUCHI M. and AGGARWAL B. B. (1994): Differential roles of two types of the TNF receptor in TNF-induced cytotoxicity, DNA fragmentation, and differentiation. J. Immunol., 152, 4017 - 4025.
28. HOHMANN H.-P., BROCKAUS M., BAUERLE P. A., REMY R., KOLBECK R. and VAN LOON A. P. G. M. (1990): Expression of the types A and B tumor necrosis factor (TNF) receptors is independently regulated, and both receptors mediate activation of the transcription factor NF-κB. TNFα is not needed for induction of a biological effect via TNF receptors. J. Biol. Chem., 265, 22409-22417.
29. Hsu H., SHU H.-B., PAN M.-G. and GOEDDEL D. V. (1996): TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell, 84, 299 - 308.
30. ITOH N. and NAGATA S. (1993): A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. J. Biol. Chem., 268, 10932 - 10937.
31. KALTHOFF H., ROEDER C., BROCKHAUS M., THIELE H.-G. and SCHMIEGEL W. (1993): Tumor necrosis factor upregulates the expression of p75 but not p55 TNF receptors, and both receptors mediate, independently of each other, up-regulation of transforming growth factor α and epidermal growth factor receptor mRNA. J. Biol. Chem., 268, 2762 - 2766.
32. KEMPER O. and WALLACH D. (1993): Cloning and partial characterization of the promoter for the human p55 tumor necrosis factor (TNF) receptor. Gene, 134, 209 - 216.
33. KOSSODO S., CRITICO B. and GRAU G. E. (1994): Modulation of the transcripts for tumor necrosis factor-α and its receptors in vivo. Eur. J. Immunol., 24, 769 - 772.
34. KRUPPA G., THOMA B., MACHLEIDT T., WIEGMANN K. and KROENKE M. (1992): Inhibition of tumor necrosis factor (TNF)-mediated NF-κB activation by selective blockade of the human 55-kDa TNF receptor. J. Immunol., 148, 3152 - 3157.
35. KUHNERT P., KEMPER O. and WALLACH D. (1995): Cloning, sequencing and partial functional characterization of the 5′ region of the human p75 tumor necrosis factor receptor-encoding gene (TNF-R). Gene, 150, 381 - 386.
36. LÁEGREID A., MEDVEDEV A., NONSTAD U., BOMBARA M., RANGES G., SUNDAN A. and ESPEVIK T. (1994): Tumor necrosis factor receptor p75 mediates cell-specific activation of nuclear factor κB and induction of human cytomegalovirus enhancer. J. Biol. Chem., 269, 7785 - 7791.
37. LANTZ M., GULLBERG U., NILSSON E. and OLSSON I. (1990): Characterization in vitro of a human tumor necrosis factor-binding protein. A soluble form of a tumor necrosis factor receptor. J. Clin. Invest., 86, 1396 - 1402.
38. LOETSCHER H., PAN Y-C.E., LAHM H.-W., GENTZ R., BROCKHAUS M., TABUCHI H. and LESSLAUER W. (1990): Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor. Cell, 61, 351 - 359.
39. MEDVEDEV A., SUNDAN A. and ESPEVIK T. (1994): Involvement of the tumor necrosis factor receptor p75 in mediating cytotoxicity and gene regulating activities. Eur. J. Immunol., 24, 2842 - 2849.
40. MUZIO M., CHINNAIYAN A. M., KISCHKEL F. C., O'ROURKE K., SHEVCHENKO A., NI J., SCAFFIDI C., BRETZ J. D., ZHANG M., GENTZ R., MANN M., KRAMMER P. H., PETER M. E. and DIXIT V. M. (1996): FLICE, a novel FADD-homologous ICE/CED-3 like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell, 85, 817 - 827.
41. NOPHAR Y., KEMPER O., BRAKEBUSCH C., ENGELMANN H., ZWANG R., ADERKA D., HOLTMANN H and WALLACH D. (1990): Soluble forms of tumor necrosis factor receptors (TNF-Rs). The cDNA for the type I TNF-R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor. EMBO J., 9, 3269 - 3278.
42. PANDITA R., POCSIK E. and AGGARWAL B. B. (1992): Interferon-γ induces cell surface expression for both types of tumor necrosis factor receptors. FEBS Lett., 312, 87 - 90.
43. PENNICA D., LAM V. T., MIZE N. K., WEBER R. F., LEWIS M., FENDLY B. M., LIPARI M. T. and GOEDDEL D. V. (1992): Biochemical properties of the 75-kDa tumor necrosis factor receptor. Characterization of ligand binding, internalization, and receptor phosphorylation. J. Biol. Chem., 267, 21172 - 21178.
44. PINCKARD J. K., SHEEHAN K. F. C. and SCHREIBER R. D. (1996): Ligand-induced formation of p55 and p75 TNF receptor heterocomplexes: a mechanism underlying TNF receptor cooperativity. Eur. Cytokine Netw., 7, 621 (abstract).
45. PORTHEU F. and HIEBLOT C. (1994): Tumor necrosis factor induces a selective shedding of its receptor from human neutrophils. J. Biol. Chem., 269, 2834 - 2840.
46. ROTHE J., BLUETHMANN H., GENTZ R., LESSLAUER W. and STEINMETZ M. (1993): Genomic organization and promoter function of the murine tumor necrosis factor receptor beta gene. Mol. Immunol., 30, 165 - 175.
47. ROTHE M., SARMA V., DIXIT V. M. and GOEDDEL D. V. (1995): TRAF2-mediated activation of NF-κB by TNF receptor 2 and CD40. Science, 269, 1424 - 1427.
48. ROTHE M., WONG S. C., HENZEL W. J. and GOEDDEL D. V. (1994): A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell, 78, 681 - 692.
49. SANTEE S. M. and OWEN-SCHAUB L. B. (1996): Human tumor necrosis factor receptor p75/80 (CD 120b) gene structure and promoter characterization. J. Biol. Chem., 271, 21151 - 21159.
50. SCHALL T. J., LEWIS M., KOLLER K. J., LEE A., RICE G. C., WONG G. H. W., GATANAGA T., GRANGER G. A., LENTZ R., RAAB H., KOHR W. J. and GOEDEEL D. V. (1990): Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell, 61, 361 - 370.
51. SCHWALB D. M., HAN H.-M., MARINO M., WARREN R., PORTER A., GOH C., FAIR W. R. and DONNER D. B. (1993): Identification of a new receptor subtype for tumor necrosis factor-α. J. Biol. Chem., 268, 9949 - 9954.
52. SMITH C. A., DAVIS T., ANDERSON D., SOLAM L., BECKMANN M. P., JERZY R., DOWER S., COSMAN D. and GOODWIN R. G. (1990): A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science, 248, 1019 - 1023.
53. SMITH C. A., FARRAH T. and GOODWIN R. G. (1994): The TNF receptor superfamily of cellular and viral proteins: activation, costimulation and death. Cell, 76, 959 - 962.
54. SMITH D. M., TRAN H. M., SOO V. M., MCQUISTON S. A., TARTAGLIA L. A., GOEDDEL D. V. and EPSTEIN L. B. (1994): Enhanced synthesis of tumor necrosis factor-inducible proteins, plasminogen activator inhibitor-1, mangenase superoxide dismutase, and protein 28/5.6, is selectively triggered by the 55-kDa tumor necrosis factor receptor in human melanoma cells. J. Biol. Chem., 269, 9898 - 9905.
55. STRATOWA C. and AUDETTE M. (1995): Transcriptional regulation of the human intercellular adhesion molecule-1 gene: a short oveview. Immunobiology, 93, 305 - 314.
56. TANNENBAUM C. S., MAJOR J. A. and HAMILTON T. H. (1993): IFN-γ and lipopolysacchride differentially modulate expression of tumor necrosis factor receptor mRNA in murine peritoneal macrophages. J. Immunol., 151, 6833 - 6839.
57. TARTAGLIA L. A., AYRES T. M., WONG G. H. W. and GOEDDEL D. V. (1993): A novel domain within the 50 kd TNF receptor signals cell death. Cell, 74, 845 - 853.
58. TARTAGLIA L. A. and GOEDEEL D. V. (1992): Two TNF receptors. Immunol. Today, 13, 151 - 153.
59. TARTAGLIA L. A. and GOEDDEL D. V. (1992): Tumor necrosis factor receptor signaling. A dominant negative mutation suppresses the activation of the 55-kDa tumor necrosis factor receptor. J. Biol. Chem., 267, 4304 - 4307.
60. TARTAGLIA L. A., GOEDDEL D. V., REYNOLDS C., FIGARI I. S., WEBER R. F., FENDLY B. M. and PALLADINO M. A. (1993): Stimulation of human T-cell proliferation by specific activation of the 75-kDa tumor necrosis factor receptor. J. Immunol., 151, 4637 - 4641.
61. TARTAGLIA L. A., PENNICA B. and GOEDDEL D. V. (1993): Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J. Biol. Chem., 268, 18542 - 18548.
62. TARTAGLIA L. A., WEBER R. F., FIGARI I. S., REYNOLDS C., PALLADINO M. A. and GOEDDEL D. V. (1991): The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc. Natl. Acad. Sci. USA, 88, 9292 - 9296.
63. TCHÓRZEWSKI H., ZEMAN K., PALEOLOG E., BRENNAN G., FELDMANN M., KAHAN M., GUGA P., KWINKOWSKI M., SZYMAŃSKA B. and JAROSZ J. (1993): The effects of tumor necrosis factor (TNF) derivatives on TNF receptors. Cytokine, 5, 125 - 132.
64. TILG H., SHAPIRO L., VANNIER E., POUTSIAKA D. D., TREHU E., ATKINS M. B., DINARELLO C. A. and MIER J. W. (1994): Induction of circulating antagonist to IL-1 and TNF by IL-2 administration and their effects on IL-2-induced cytokine production in vitro. J. Immunol., 152, 3189 - 3198.
65. TILG H., TREHU E., SHAPIRO L., PAPE D., ATKINS M. B., DINARELLO C. A. and MIER J. W. (1994): Induction of circulating soluble tumor necrosis factor receptor and interleukin 1 receptor antagonist following interleukin 1α infusion in humans. Cytokine, 6, 215 - 219.
66. TILG H., VOGEL W. and DINARELLO C. A. (1995): Interferon-α induces circulating tumor necrosis factor receptor p55 in humans. Blood, 85, 433 - 435.
67. TREFZER U., BROCKHAUS M., LOETSCHER H., PARLOW F., BUDNIK A., GREWE M., CHRISTOPH H., KAPP A., SCHOPF E., LUGER T. A. and KRUTMANN J. (1993): The 55-kD tumor necrosis factor receptor on human keratinocytes is regulated by tumor necrosis factor-alpha and by ultraviolet B radiation. J. Clin. Invest., 92, 462 - 470.
68. VANDENABEELE P., DECLERQ W., VANHAESEBROECK B., GROOTEN J. and FIERS W. (1995): Both TNF receptors are required for TNF-mediated induction of apoptosis in PC60 cells. J. Immunol., 154, 2904 - 2913.
69. VANDENABEELE P., DECLERQ W., VERCAMMEN D., DE CRAEN M., GROOTEN J., LOETSCHER H., BROCKHAUS W., LESSLAUER W. and FIERS W. (1992): Functional characterization of the human tumor necrosis factor receptor p75 in a transfected rat/mouse T cell hybridoma. J. Exp. Med., 176, 1015 - 1024.
70. VAN DER POLL T., JANSEN J., VAN LEHNEN D., VON DER MDHLEN M., LEVI M., TEN CATE H., GALLATI H., TEN CATE J. W. and VAN DEVENTER S. J. (1993): Release of soluble receptors for tumor necrosis factor in clinical sepsis and experimental endotoxemia. J. Infect. Dis., 168, 955 - 960.
71. VAN OSTADE X., VANDENABEELE P., EVERAERDT B., LOETSCHER H., GENTZ R., BROCKHAUS M., LESSLAUER W., TAVERNIER J., BROUCKAERT P. and FIERS W. (1993): Human TNF mutants with selective activity on the p55 receptor. Nature, 361, 266 - 269.
72. VOGELS M. T. E., MENSINK E. J. B. M., YE K., BOERMAN O. C., VERSCHUEREN C. M. M., DINARELLO C. A., and VAN DER MEER J. W. M. (1994): Differential gene expression for IL-1 receptor antagonist, IL-1, and TNF receptors and IL-1 and TNF synthesis may explain IL-1 induced resistance to infection. J. Immunol., 153, 5772 - 5780.
73. WARE C. F., CROWE P. D., VANARSDALE T. L., ANDREWS J. L., GRAYSON M. H., JERZY R., SMITH C. A. and GOODWIN R. G. (1991): Tumor necrosis factor (TNF) receptor expression in T-lymphocytes. Differential regulation of the type I TNF receptor during activation of resting and effector T cells. J. Immunol., 147, 4229 - 4238.
74. WARE C. F., VANARSDALE S. and VANARSDALE T. L. (1996): Apoptosis mediated by the TNF-related cytokine and receptor families. J. Cell. Biochem., 60, 47 - 55.
75. WINZEN R., KAFERT S., PREISS B., MYLIUS-SPENCKER H. A., RESCH K. and HOLTMANN H. (1996): Interaction between the mRNA of the 55 kDa tumor necrosis factor receptor and cellular proteins: possible involvement in post-transcriptional regulation of receptor expression. J. Biol. Chem., 271, 13461 - 13467.
76. WINZEN R., WALLACH D., ENGELMANN H., NOPHAR Y., BRAKEBUSCH C., KEMPER O., RESCH K. and HOLTMANN H. (1992): Selective decrease in the cell surface expression and mRNA level of the 55-kDa tumor necrosis factor receptor during differentiation of HL-60 cells into makrophage-like but not granulocyte-like cells. J. Immunol., 148, 3454 - 3460.
77. WINZEN R., WALLACH D., KEMPER O., RESCH K. and HOLTMANN H. (1993): Selective up-regulation of the 75-kDa tumor necrosis factor receptor and its mRNA by TNF and IL-1. J. Immunol., 150, 4346 - 4353.
78. WONG G. H. W., TARTAGLIA L. A. and GOEDDEL D. V. (1992): Antiviral activity of tumor necrosis factor is signaled through the 55-kDa type 1 TNF receptor. J. Immunol., 149, 3550 - 3553.